Market Overview

Trade CBD stock with recommended broker Ally Invest. Commissions as low as $3.95.

Analyst Rating View All Ratings

DateResearch FirmActionCurrentTarget
11/07/17Credit SuisseUpgradesNeutralOutperform
11/03/16HSBCUpgradesReduceHold
11/09/15NomuraDowngradesBuyNeutral
Show more Loading articles...

Earnings View Earnings

Q2 2018 EST Actual Surprise
EPS: 0.15 0.45 0.3
Rev: 3.17B
Q3 2018 EST Actual Surprise
EPS: Expected
2018-10-25
Rev:

Company Profile